Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Feb 09, 2021 2:46pm
88 Views
Post# 32515402

RE:RE:RE:RE:RE:RE:TH is dead money

RE:RE:RE:RE:RE:RE:TH is dead money That being said, I am totally in favor of improving the website and making more info easily available, like scientific papers, archiving webcasts of presentations, etc...

My point is that I just don't think it will make the difference on the stock price. Most small investors in thechnology stocks rely on percieved credibility and odds of success. It comes from outside validation and momentum building, and most importantly, hard facts. If Thera is to be successful there will be a trigger point for that. It happened on the Trogarzo story, and before that the Egrifta story, but both ended in disapointment. So skepticism will prevail until they can come up with more than hope.


jfm1330 wrote: There is enough on Thera's website to know what the company is doing and to understand the general principles behind their clinical programs. Sorry, but if you don't have the proper scientific background, more advanced scientific explainations won't be understandable. I don't want to look more intelligent than anybody by saying that, it is just a matter of mastering enough pertinent scientific principles, and if you do, you can do your own litterature review to further understand what they are doing and where it stands in the larger context, including possible competition, odds of success based on history, etc....

scarlet1967 wrote: I was asked on Stocktwits from a share holder whether the company reverse fibrosis or not?
Shareholder there are asking what NASH means?
Shareholders there ask where they can find company's investor presentation on the website and when the find it they can't understand it?
Other comparable companies have much higher followers on Twitter, Stocktwits, yahoo finance chat sector and even on this MB!
The company is definitely unknown and certainly not understood.




<< Previous
Bullboard Posts
Next >>